✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹2,140 Cr.
P/E
42.79
About
Vimta Labs Limited, established in 1984, provides analytical, clinical, preclinical services to life sciences industries, quality testing for food and beverage sectors, and environment services to var… Read more
Vimta Labs Limited, established in 1984, provides analytical, clinical, preclinical services t… Read more
Low
400
52W Range
High
1070
  • Vimta Labs
  • Krsnaa Diagnostics
  • Nidan Labs. & Health
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    FAQs on Vimta Labs Ltd. Business

    Founded in 1984, Vimta Labs Limited provides analytical, clinical, and preclinical services to life sciences industries, quality testing for food and beverage sectors, and environmental services globally.

    Vimta Labs major competitors are Krsnaa Diagnostics, Nidan Labs. & Health, Thyrocare Tech., Vijaya Diagnostic, Metropolis Health., Dr. Lal Pathlabs, Amrutanjan Healthcar.
    Market Cap of Vimta Labs is ₹2,140 Crs.
    While the median market cap of its peers are ₹5,028 Crs.

    Vimta Labs seems to be less financially stable compared to its competitors.
    Altman Z score of Vimta Labs is 20.22 and is ranked 5 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Jun Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis